← Back to patent-cliff list
CAS 577-59-3
1-(2-nitrophenyl)ethan-1-one
Codes: BELOH-001
Application context (from source-drug indications)
Non-small cell lung cancerBelotecan HydrochlorideOvarian cancerBelotecan HydrochlorideSolid tumourBelotecan Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Belotecan Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(2-nitrophenyl)ethan-1-one→propan-2-amine→benzyl isopropyl(3-(2-nitrophenyl)-3-oxopropyl)carbamate→benzyl (3-(2-aminophenyl)-3-oxopropyl)(isopropyl)carbamate→(S)-4-ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione→benzyl (S)-(2-(4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-11-yl)ethyl)(isopropyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.